CJSC «EKOlab».
«First Moscow State Medical University after I.M. Sechenov» of the Ministry of Healthcare of the Russian Federation (1st MSMU after I.M. Sechenov).
Klin Lab Diagn. 2022 Apr 17;67(4):227-233. doi: 10.51620/0869-2084-2022-67-4-227-233.
The paper present the results of a survey of people who have undergone immunization with a combined vector vaccine for the prevention of coronavirus infection COVID-19 «Sputnik V - Gam-COVID-Vac», as well as COVID-19 recovalents. Using a quantitative enzyme-linked immunosorbent assay, the levels of specific IgG were determined in persons who had had different degrees of severity before vaccination, in persons who were immuno-negative before immunization, as well as in convalescents who had undergone coronavirus infection of varying severity. The immunological targeting of antibodies against various SARS-CoV-2 proteins is considered.
本文介绍了一项针对已接种预防冠状病毒感染 COVID-19 的联合载体疫苗“卫星 V-Gam-COVID-Vac”的人群以及 COVID-19 康复者的调查结果。使用定量酶联免疫吸附试验,在接种前病情严重程度不同的人群、接种前免疫阴性的人群以及经历过不同严重程度冠状病毒感染的康复者中,测定了特异性 IgG 水平。考虑了针对各种 SARS-CoV-2 蛋白的抗体的免疫靶向性。